Cargando…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
RATIONALE: Major depressive disorder is one of the leading global causes of disability, for which the classic serotonergic psychedelics have recently reemerged as a potential therapeutic treatment option. OBJECTIVE: We present the first meta-analytic review evaluating the clinical effects of classic...
Autores principales: | Galvão-Coelho, Nicole L., Marx, Wolfgang, Gonzalez, Maria, Sinclair, Justin, de Manincor, Michael, Perkins, Daniel, Sarris, Jerome |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826317/ https://www.ncbi.nlm.nih.gov/pubmed/33427944 http://dx.doi.org/10.1007/s00213-020-05719-1 |
Ejemplares similares
-
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023) -
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
por: Schindler, Emmanuelle A. D., et al.
Publicado: (2018) -
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
por: Lowe, Henry, et al.
Publicado: (2022) -
Serotonergic Psychedelics in Neural Plasticity
por: Lukasiewicz, Kacper, et al.
Publicado: (2021) -
Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms
por: Schweitzer, Isaac, et al.
Publicado: (2013)